Amyotrophic lateral sclerosis (ALS), also called motor neuron disease, Lou Gehrig's disease or Charcot's disease, is a rare terminal neurodegenerative illness in which both upper and lower motor neurons, the cells controlling voluntary muscle movement, progressively die. It is the most common of the motor neuron diseases. Symptoms often begin with muscle stiffness, twitching, weakness and wasting, and the loss of motor neurons usually continues until a person can no longer eat, speak, move or breathe without mechanical support. At least half of those affected experience notable changes in thinking or behavior.
Types and causes






ALS is classified by which motor neurons are affected, which body region symptoms begin in, whether it is genetic, and the age of onset. Most cases, roughly 90 to 95 percent, have no known cause and are called sporadic. Genetic, autoimmune and environmental factors are thought to play a part. About 5 to 10 percent of cases have a known genetic origin and are often linked to family history, with mutations in the C9orf72 gene being the most common known genetic cause.
Treatment and outlook






There is currently no cure for ALS, so treatment aims to slow progression and ease symptoms. Two drugs approved by the US Food and Drug Administration, riluzole and edaravone, slow the disease. Non-invasive ventilation may improve both quality and length of life, while mechanical ventilation can prolong survival without halting progression. A feeding tube can help maintain nutrition. Death is usually caused by respiratory failure. The disease can affect people of any age but usually begins around 60, and average survival from onset is two to four years, though about 10 percent of those affected live beyond ten years.
